Organogenesis investor relations 5 days ago · Organogenesis delivered record third-quarter revenue in 2025 with a significant surge in Advanced Wound Care sales and a robust increase in adjusted EBITDA, prompting the company to raise its full-year guidance. , Nov. Feb 27, 2025 · The live webcast can also be accessed via the company’s website at investors. 's business for stockholders, potential investors, and financial analysts. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance November 06, 2025 16:05 ET | Source: Organogenesis Holdings Inc. , March 01, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. 6 days ago · Organogenesis Holdings Inc. , May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. Our leadership team is dedicated to developing and delivering safe, effective, and evidence-based product solutions to clinicians and their patients every day with confidence, expertise, and certainty. Get the free ORGANOGENESIS HOLDINGS INC. C. com Moved Permanently Oct 14, 2020 · A live webcast of the call will also be provided on the investor relations section of the Company's website at investors. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization Sep 5, 2024 · A webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www. Jan 27, 2025 · Discover what to expect from Organogenesis Holdings' financial results report, including conference call details and company's advancements in regenerative medicine. 20549FORM 8K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of The Earliest We are not affiliated with any brand or entity on this form 4,4 98,753 Reviews 4,5 11,210 Reviews 4,6 715 Feb 29, 2024 · CANTON, Mass. com. (the Company ) announced via press release its results for the fiscal fourth quarter and year ended December 31, 2020. Feb 27, 2025 · We appreciate the support from a leading healthcare investor and believe it reflects Avista's confidence in the compelling opportunity investing in Organogenesis presents. Feb 28, 2025 · Operator: Please standby. ET and the Morgan Stanley Global Healthcare May 8, 2025 · --Organogenesis Holdings Inc. May 8, 2025 · --Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported. Organogenesis delivers regenerative tissue innovations in advanced wound care, surgery, and sports medicine, empowering healing with leading products and support. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization Feb 27, 2025 · Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Organogenesis Holdings Inc. Mar 1, 2023 · CANTON, Mass. Get Organogenesis Holdings Inc (ORGO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The webcast will be archived on the company website for approximately one year. - Investor Relations Get Form Show details UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. 5 days ago · See the latest Organogenesis Holdings Inc Class A stock price (ORGO:XNAS), related news, valuation, dividends and more to help you make your investing decisions. (ORGO) using our online tools. Aug 27, 2025 · Webcasts of the fireside chat sessions will be accessible by visiting the “News & Events” section on the “Investor Relations” page of Organogenesis’s website www. (ORGO) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ETCompany ParticipantsGary S. 6 days ago · Welcome to our dedicated page for Organogenesis Hldgs SEC filings (Ticker: ORGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. , a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the Feb 28, 2025 · We appreciate the support from a leading healthcare investor and believe it reflects Avista's confidence in the compelling opportunity investing in Organogenesis presents. Oct 1, 2025 · CANTON, Mass. Stay informed with the latest financial disclosures, quarterly results, and key announcements from the company. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. Cl A (ORGO) stock price, news, historical charts, analyst ratings and financial information from WSJ. While Q3 performance stands out, investors will want to weigh persistent operational challenges, trends in cash flow, and new regulatory dynamics shaping the company's future. [Operator Instructions] Please note that this conference call is being recorded Sep 3, 2025 · Access Organogenesis (ORGO) IR material: earnings summary, earnings date, guidance, transcripts, filings & reports, and live & recorded earnings calls. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization View the latest Organogenesis Holdings Inc. Management will present at the Cantor Fitzgerald Global Healthcare Conference on September 3 at 2:10 p. An archive of the webcast will be available for replay following the conference for approximately 30 days. May 10, 2023 · A live webcast of the call will also be provided on the investor relations section of the Company's website at investors. About Organogenesis Holdings Inc. Organogenesis Holdings Inc (NASDAQ:ORGO) investor relations materials: earnings calls, slides & pdfs, and letter to shareholders. m. organogenesis. Apr 7, 2025 · About Organogenesis Holdings Inc. Feb 28, 2025 · Organogenesis Holdings Inc. , a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical On March 16, 2021, Organogenesis Holdings Inc. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc. The Investor Relations website contains information about Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the Feb 27, 2025 · CANTON, Mass. A live audio webcast of the conference presentation will be accessible by visiting the "Upcoming Events" section on the "Investor Relations" page of Organogenesis's website www. Feb 27, 2025 · --Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through LEADERSHIP Organogenesis is led by a passionate team of executives and medical professionals whose core mission is to empower healing through regenerative medicine. . (ORGO) is a leader in regenerative medicine, specializing in advanced wound care and surgical biologics. Aug 27, 2025 · Organogenesis Holdings (Nasdaq: ORGO), a regenerative medicine company specializing in Advanced Wound Care and Surgical & Sports Medicine markets, has announced its participation in two major healthcare investor conferences in September. This page aggregates all official company announcements, press releases, and Sep 4, 2024 · A webcast of the conference presentation will be accessible by visiting the “Upcoming Events” section on the “Investor Relations” page of Organogenesis’s website www. Organogenesis Holdings Inc. Get the latest Organogenesis Holdings Inc (ORGO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. May 8, 2025 · CANTON, Mass. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. Access Organogenesis Holdings’ official earnings reports, SEC filings, and shareholder updates. 5 days ago · Welcome, ladies and gentlemen, to the Third Quarter 2025 Earnings Conference Call of Organogenesis Holdings, Inc. 6 days ago · Welcome to our dedicated page for Organogenesis Hldgs news (Ticker: ORGO), a resource for investors and traders seeking the latest updates and insights on Organogenesis Hldgs stock. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. Feb 27, 2025 · About Organogenesis Holdings Inc. 06, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. , Feb. wmyufi 36tx 2i9 4lh 76jxv bir7a en7st ef emp6 3pyld